X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs LUPIN LTD - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS LUPIN LTD J.B.CHEMICALS/
LUPIN LTD
 
P/E (TTM) x 17.2 28.5 60.2% View Chart
P/BV x 2.3 2.7 85.1% View Chart
Dividend Yield % 0.2 0.6 27.4%  

Financials

 J.B.CHEMICALS   LUPIN LTD
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
LUPIN LTD
Mar-18
J.B.CHEMICALS/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs3181,465 21.7%   
Low Rs200727 27.4%   
Sales per share (Unadj.) Rs148.0349.6 42.3%  
Earnings per share (Unadj.) Rs19.15.6 343.4%  
Cash flow per share (Unadj.) Rs23.929.6 81.0%  
Dividends per share (Unadj.) Rs0.505.00 10.0%  
Dividend yield (eoy) %0.20.5 42.4%  
Book value per share (Unadj.) Rs128.9300.3 42.9%  
Shares outstanding (eoy) m84.82452.08 18.8%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x1.73.1 55.8%   
Avg P/E ratio x13.6197.2 6.9%  
P/CF ratio (eoy) x10.837.1 29.2%  
Price / Book Value ratio x2.03.6 55.0%  
Dividend payout %2.690.0 2.9%   
Avg Mkt Cap Rs m21,951495,502 4.4%   
No. of employees `0002.717.0 16.0%   
Total wages/salary Rs m1,84128,647 6.4%   
Avg. sales/employee Rs Th4,590.99,273.6 49.5%   
Avg. wages/employee Rs Th673.41,681.0 40.1%   
Avg. net profit/employee Rs Th592.1147.4 401.6%   
INCOME DATA
Net Sales Rs m12,551158,042 7.9%  
Other income Rs m5421,504 36.0%   
Total revenues Rs m13,093159,545 8.2%   
Gross profit Rs m2,05531,475 6.5%  
Depreciation Rs m41210,859 3.8%   
Interest Rs m962,044 4.7%   
Profit before tax Rs m2,08820,076 10.4%   
Minority Interest Rs m0-71 0.6%   
Prior Period Items Rs m035 0.0%   
Extraordinary Inc (Exp) Rs m0-14,644 0.0%   
Tax Rs m4692,885 16.3%   
Profit after tax Rs m1,6192,513 64.4%  
Gross profit margin %16.419.9 82.2%  
Effective tax rate %22.514.4 156.3%   
Net profit margin %12.91.6 811.2%  
BALANCE SHEET DATA
Current assets Rs m7,778122,095 6.4%   
Current liabilities Rs m4,35850,956 8.6%   
Net working cap to sales %27.245.0 60.5%  
Current ratio x1.82.4 74.5%  
Inventory Days Days5585 64.6%  
Debtors Days Days80120 66.7%  
Net fixed assets Rs m5,713129,876 4.4%   
Share capital Rs m170904 18.8%   
"Free" reserves Rs m10,547134,866 7.8%   
Net worth Rs m10,937135,771 8.1%   
Long term debt Rs m064,245 0.0%   
Total assets Rs m15,574263,054 5.9%  
Interest coverage x22.810.8 210.8%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.80.6 134.1%   
Return on assets %11.01.7 635.6%  
Return on equity %14.81.9 799.7%  
Return on capital %20.03.7 536.7%  
Exports to sales %48.70-   
Imports to sales %7.10-   
Exports (fob) Rs m6,115NA-   
Imports (cif) Rs m889NA-   
Fx inflow Rs m6,16953,141 11.6%   
Fx outflow Rs m1,28519,335 6.6%   
Net fx Rs m4,88433,807 14.4%   
CASH FLOW
From Operations Rs m1,39717,512 8.0%  
From Investments Rs m-320-14,073 2.3%  
From Financial Activity Rs m-1,196-14,921 8.0%  
Net Cashflow Rs m-102-11,482 0.9%  

Share Holding

Indian Promoters % 55.4 46.6 118.9%  
Foreign collaborators % 0.3 0.2 150.0%  
Indian inst/Mut Fund % 3.4 11.3 30.0%  
FIIs % 3.9 31.9 12.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.1 366.3%  
Shareholders   30,437 98,259 31.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   IPCA LABS  SANOFI INDIA  DR. DATSONS LABS  MERCK LTD  NOVARTIS  

Compare J.B.CHEMICALS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 629 Points Higher; Realty and Auto Stocks Witness Buying(Closing)

Indian share markets continued their momentum throughout the day and ended the day on a strong note. Gains were largely seen in the realty sector, telecom sector and auto sector.

Related Views on News

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Dec 12, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS